Tomorrow’s World in Medicines
To address the potential medicines of tomorrow, a panel of experts will discuss emerging therapies and the potential of developing new medicines and repurposing old medicines on Tuesday Nov. 5, 2019 at CPhI in Frankfurt, Germany.
Emerging therapeutic areas, such as oncology, cardiovascular, autoimmune, pulmonary, and mental health, are becoming more and more important for pharma companies. These conditions often encompass complex and difficult disease processes that can require individualized treatment.
To address the potential medicines of tomorrow, a panel of experts will discuss emerging therapies and the potential of developing new medicines and repurposing old medicines on Tuesday Nov. 5, 2019 at CPhI in Frankfurt, Germany. Some of the topics for consideration will be value added medicines, personalized therapies, the market shift towards niche therapies, and the future of generics.
The panel of experts participating in the discussion will be Aurelio Arias (IQVIA), Subodh Deshmukh (Sandoz), Ken Phelps (Camargo Pharmaceutical Services), Dr. Thomas Solbach (Strategy&), Paul Thorning (Crystec Pharma), and Dr. Andreas Wicki (KSBL).
The Future of Medicine: What are the therapies of tomorrow?Tuesday Nov. 5, 201910:30–11:40CPhI Theatre (61D61)
UK Medicines Manufacturing Skills Centre Stresses Skill Development after Budget Announcement
November 8th 2024A £520 million investment for manufacturing capacity was announced by Chancellor of the Exchequer, Rachel Reeves, but academic and industry leaders stress the money should be used to train personnel.
